Canopy Growth’s Net Revenue Climbs 22.5% To $135.3 Million In Q2, Records Loss Of $96.6 Million

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) this morning reported its second quarter 2021 financial results, reporting net revenues of $135.3 million along with a net loss of $96.6 million for the period ended September 30, 2020. Revenues were up significantly on a quarter over quarter basis, with growth amounting to 22.5%.

Revenue growth largely comes from Canadian recreational net revenue, which saw the overall sales figure rise from $44.2 million to $60.9 million over the three month period. Dry bud sales specifically is what drove the increase, which rose to $63.9 million on a gross basis from that of $40.1 million. Global medical revenue actually fell to $31.4 million from $34.1 million over the quarter, while other revenue climbed from $32.1 million to $43.0 million.

Cost of goods sold meanwhile came in at $109.2 million, providing the company with a gross margin of $26.0 million. This still was not enough to cover operating expenses however, which came in at $310.3 million this quarter. This was largely comprised of selling, general and administrative expenses of $147.3 million, but also included asset impairment charges of $46.4 million and expected credit losses on financial assets and related charges of $94.7 million.

Combined with other income of $221.3 million, the company managed to post a net loss of $96.6 million for the three month period.

Looking to the balance sheet, cash and cash equivalents fell significantly, dropping to $673.3 million from $975.9 million over the three month period, while short term investments were relatively flat overall, dropping to $1,048.9 million from $1,060.9 million in the prior period. Accounts receivable meanwhile grew from $72.6 million to $79.7 million, and inventory increased marginally from $389.8 million to $398.5 million. Total current assets fell to $2,291.9 million from $2,613.9 million.

Accounts payable meanwhile managed to fall to $81.1 million from $89.4 million over the course of the quarter. Other liabilities more than made up for this however, growing to $147.1 million from $124.8 million. Current liabilities overall climbed from $319.7 million to $324.5 million.

Full financial results have yet to be released as of the time of writing.

Canopy Growth Corp last traded at $23.50 on the NYSE.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

First Majestic Tracking Ahead Of Guidance Following Q1 Production Results

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Related News

Canopy Growth Names New Chair of the Board

Canopy Growth Corp (TSX: WEED) (NYSE: CGC) has performed a slight shake up to its...

Wednesday, January 22, 2020, 08:27:36 AM

Fired Again! Vireo Health Terminates Bruce Linton As Executive Chairman

It’s been a rough year for Bruce Linton. After being terminated last July as co-CEO...

Monday, June 8, 2020, 06:30:50 PM

Canopy Growth Sees Gross Margins Improve To 3%, Net Losses Continue In Q2 2023

Despite the recent excitement surrounding its decision to enter the US cannabis market more directly,...

Wednesday, November 9, 2022, 08:16:26 AM

Canopy Growth Posts Q3 2021 Revenues Of $152.5 Million, Net Loss Of $829.3 Million

Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) this morning released its third quarter 2021 financial...

Tuesday, February 9, 2021, 07:28:44 AM

Constellation Brands Lets Canopy Growth Warrants Expire Unexercised

Constellation Brands (NYSE: STZ) appears to have walked away from the idea of investing further...

Sunday, November 5, 2023, 11:36:00 AM